Gyre Therapeutics (GYRE) Other Working Capital Changes (2010 - 2026)
Gyre Therapeutics (GYRE) reported Other Working Capital Changes of $912000.0 for Q1 2026, down 83.54% year-over-year from $5.5 million in Q1 2025, and up 79.17% on a QoQ basis from $509000.0 in Q4 2025.
Gyre Therapeutics (GYRE) has 17 years of Other Working Capital Changes data on file, last reported at $912000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 83.54% year-over-year to $912000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.4 million (down 209.48% YoY) and the FY2025 annual result came in at $10945.0, down 52.41% from the prior year.
- Other Working Capital Changes grew to $912000.0 in Q1 2026 per GYRE's latest filing, from $509000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $5.5 million in Q1 2025 and bottomed at -$5.4 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is $14729.0 (2023), against an average of -$137531.2.
- The widest annual swing landed in 2022, when Other Working Capital Changes soared 8216.17%; it then tumbled 2802.15% in 2024.
- Tracing GYRE's Other Working Capital Changes over 5 years: stood at -$743000.0 in 2022, then climbed by 23.69% to -$567000.0 in 2023, then tumbled by 210.41% to -$1.8 million in 2024, then surged by 128.92% to $509000.0 in 2025, then jumped by 79.17% to $912000.0 in 2026.
- Per Business Quant, the three latest GYRE Other Working Capital Changes figures stand at $912000.0 (Q1 2026), $509000.0 (Q4 2025), and -$398000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 912,000.00 |
| Mar 31, 2026 | 912,000.00 |
| Dec 31, 2025 | 509,000.00 |
| Dec 31, 2025 | 509,000.00 |
| Sep 30, 2025 | -398,000.00 |
| Sep 30, 2025 | -398,000.00 |
| Jun 30, 2025 | -5.45 Mn |
| Jun 30, 2025 | -5.45 Mn |
| Mar 31, 2025 | 5.54 Mn |
| Mar 31, 2025 | 5.54 Mn |
| Dec 31, 2024 | -1.76 Mn |
| Dec 31, 2024 | -1.76 Mn |
| Sep 30, 2024 | -398,000.00 |
| Sep 30, 2024 | -398,000.00 |
| Jun 30, 2024 | 657,000.00 |
| Jun 30, 2024 | 657,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | -567,000.00 |
| Dec 31, 2023 | -567,000.00 |
| Sep 30, 2023 | 14,729.00 |
| Sep 30, 2023 | 14,729.00 |
| Jun 30, 2023 | 14,729.00 |
| Jun 30, 2023 | 14,729.00 |
| Mar 31, 2023 | -808,000.00 |
| Mar 31, 2023 | -808,000.00 |
| Dec 31, 2022 | -743,000.00 |
| Dec 31, 2022 | -743,000.00 |
| Sep 30, 2022 | 47,319.00 |
| Sep 30, 2022 | 47,319.00 |
| Jun 30, 2022 | 47,192.00 |
| Jun 30, 2022 | 47,192.00 |
| Mar 31, 2022 | -1.49 Mn |
| Mar 31, 2022 | -1.49 Mn |
| Dec 31, 2021 | -623,000.00 |
| Dec 31, 2021 | -623,000.00 |
| Sep 30, 2021 | 569.00 |
| Sep 30, 2021 | 569.00 |
| Jun 30, 2021 | 569.00 |
| Jun 30, 2021 | 569.00 |
| Mar 31, 2021 | 1.67 Mn |
| Mar 31, 2021 | 1.67 Mn |
| Dec 31, 2020 | 3.27 Mn |
| Dec 31, 2020 | 3.27 Mn |
| Sep 30, 2020 | 16,337.00 |
| Sep 30, 2020 | 16,337.00 |
| Jun 30, 2020 | 4,751.00 |
| Jun 30, 2020 | 4,751.00 |
| Mar 31, 2020 | -1.88 Mn |
| Mar 31, 2020 | -1.88 Mn |
| Dec 31, 2019 | 13,000.00 |
| Dec 31, 2019 | 13,000.00 |
| Sep 30, 2019 | 10,698.00 |
| Sep 30, 2019 | 10,698.00 |
| Jun 30, 2019 | 7,474.00 |
| Jun 30, 2019 | 7,474.00 |
| Mar 31, 2019 | -96,000.00 |
| Mar 31, 2019 | -96,000.00 |
| Dec 31, 2018 | -2.44 Mn |
| Dec 31, 2018 | -2.44 Mn |
| Sep 30, 2018 | 15,667.00 |
| Sep 30, 2018 | 15,667.00 |
| Jun 30, 2018 | 1,146.00 |
| Jun 30, 2018 | 1,146.00 |
| Mar 31, 2018 | 407,000.00 |
| Mar 31, 2018 | 407,000.00 |
| Dec 31, 2017 | 440,000.00 |
| Dec 31, 2017 | 440,000.00 |
| Sep 30, 2017 | 141.00 |
| Sep 30, 2017 | 141.00 |
| Jun 30, 2017 | 141.00 |
| Jun 30, 2017 | 141.00 |
| Mar 31, 2017 | -71,000.00 |
| Mar 31, 2017 | -71,000.00 |
| Dec 31, 2016 | -71,000.00 |
| Dec 31, 2016 | -71,000.00 |
| Sep 30, 2016 | 101,000.00 |
| Sep 30, 2016 | 101,000.00 |
| Jun 30, 2016 | -149,000.00 |
| Jun 30, 2016 | -149,000.00 |
| Mar 31, 2016 | -281,000.00 |
| Mar 31, 2016 | -281,000.00 |
| Dec 31, 2015 | -1.81 Mn |
| Dec 31, 2015 | -1.81 Mn |
| Sep 30, 2015 | 1.59 Mn |
| Sep 30, 2015 | 1.59 Mn |
| Jun 30, 2015 | -1.78 Mn |
| Jun 30, 2015 | -1.78 Mn |
| Mar 31, 2015 | 247,000.00 |
| Mar 31, 2015 | 247,000.00 |
| Dec 31, 2014 | -185,000.00 |
| Dec 31, 2014 | -185,000.00 |
| Sep 30, 2014 | -276,000.00 |
| Sep 30, 2014 | -276,000.00 |
| Jun 30, 2014 | 283,000.00 |
| Jun 30, 2014 | 283,000.00 |
| Mar 31, 2014 | -135,000.00 |
| Mar 31, 2014 | -135,000.00 |
| Dec 31, 2013 | 2.92 Mn |
| Dec 31, 2013 | 2.92 Mn |
| Sep 30, 2013 | -540,000.00 |
| Sep 30, 2013 | -540,000.00 |
| Jun 30, 2013 | 271,000.00 |
| Jun 30, 2013 | 271,000.00 |
| Mar 31, 2013 | 141,000.00 |
| Mar 31, 2013 | 141,000.00 |
| Dec 31, 2012 | -330,000.00 |
| Dec 31, 2012 | -330,000.00 |
| Sep 30, 2012 | -2.13 Mn |
| Sep 30, 2012 | -2.13 Mn |
| Jun 30, 2012 | 1.48 Mn |
| Jun 30, 2012 | 1.48 Mn |
| Mar 31, 2012 | -1.04 Mn |
| Mar 31, 2012 | -1.04 Mn |
| Dec 31, 2011 | 6.01 Mn |
| Dec 31, 2011 | 6.01 Mn |
| Sep 30, 2011 | -584,000.00 |
| Sep 30, 2011 | -584,000.00 |
| Jun 30, 2011 | 1.01 Mn |
| Jun 30, 2011 | 1.01 Mn |
| Mar 31, 2011 | -685,000.00 |
| Mar 31, 2011 | -685,000.00 |
| Dec 31, 2010 | 76,000.00 |
| Dec 31, 2010 | 76,000.00 |
| Sep 30, 2010 | 10.48 Mn |
| Sep 30, 2010 | 10.48 Mn |